Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Improving the Design of New Protein Structures
Scientific Advances

Improving the Design of New Protein Structures

By Melissa RohmanOct 27, 2022
Share
Facebook Twitter Email
Gabriel Rocklin, PhD, assistant professor of Pharmacology, was senior author of the study published in Proceedings of the National Academy of Sciences.

Northwestern Medicine investigators have solved a challenging protein design puzzle using a unique high-throughput approach, according to a study published in Proceedings of the National Academy of Sciences.

The approach could enhance the development of new therapeutics and biotechnology tools, according to Gabriel Rocklin, PhD, assistant professor of Pharmacology and senior author of the study.

“The lessons from designing ɑββɑ proteins are important for any computational protein design effort, including designing new therapeutics,” said Rocklin, who is also a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and of the Chemistry of Life Processes Institute.

Protein folding is an essential cellular process that enables proteins to function properly and avoid contributing to disease. One major challenge in computationally designing new protein structures in a laboratory is that most designed proteins are unable to fold into their designed structures when tested.

In previous work, Rocklin’s team identified the ɑββɑ fold is unusually challenging to design despite its simple structure, with the best designs having just a two percent success rate. To resolve this issue, Rocklin’s team tested thousands of new ɑββɑ designs and used machine learning methods to examine the properties of stable and unstable designs.

“ɑββɑ proteins have a very simple fold that looks like the letter ‘M’. This structure is much simpler than most naturally occurring proteins, which makes it a good testing ground that we can use to understand and improve protein design,” Rocklin said.

In the current study, the investigators designed over 10,000 new ɑββɑ proteins and by using specialized high-throughput experiments discovered that more than one-third of them folded into stable structures. The investigators were also able to identify the biophysical properties that stabilize ɑββɑ proteins as well as compare different protein design methods, according to Rocklin.

“By making changes to our design protocol, we increased our design success rate from two percent to above 30 percent. This clarified better ways to design ɑββɑ proteins and also helped us understand what makes them stable or unstable,” Rocklin said.

The current approach is applicable for any computational protein design effort. Additionally, ɑββɑ proteins also have the potential to be developed into therapeutics by modifying their surfaces so they can bind to therapeutic targets, according to Rocklin.

“These proteins can become even more stable by connecting the two ends of the ‘M’ together to form a loop, which could be an exciting strategy for designing therapeutics,” Rocklin added.

Co-lead authors of the study were Tae-Eun Kim, a student in the Driskill Graduate Program in Life Sciences (DGP), and Kotaro Tsuboyama, PhD, a postdoctoral fellow in the Rocklin laboratory. Co-authors include DGP students Claire Phoumyvong and Cydney Martell.

This work was supported in part by the National Institute of General Medical Sciences through awards 1DP2GM140927 and 5T32GM105538.

Cancer Pharmacology Research
Share. Facebook Twitter Email

Related Posts

Mar 29, 2023

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

The Future of IgE-Mediated Allergy Research and Treatments

Mar 29, 2023

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Comments are closed.

Latest News

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

The Future of IgE-Mediated Allergy Research and Treatments

Mar 29, 2023

Weintraub Appointed to Illinois Supreme Court Commission on Elder Law

Mar 28, 2023

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.